Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Geranylgeranyl Pyrophosphate Synthase Gene Polymorphisms and Bone Phenotypes and Response to Alendronate Treatment in Chinese Osteoporotic Women.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih - 20 Mar 2016

Han Lan-Wen, Ma Dou-Dou, Xu Xiao-Jie, Lü Fang, Liu Yi, Xia Wei-Bo, Jiang Yan, Wang Ou, Xing Xiao-Ping, Li Mei

Abstract excerpt

Objective To investigate the relationship between geranylgeranyl pyrophosphate synthase (GGPPS) gene polymorphisms and bone response to alendronate in Chinese osteoporotic women.Methods A total of 639 postmenopausal women with osteoporosis or osteopenia were included and randomly received treatment of low dose (70 mg per two weeks) or standard dose (70 mg weekly) of alendronate for one year. The six tag single...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Density

Share to Osteoporosis, Postmenopausal

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 28031082
DOI: 10.1016/s1001-9294(16)30016-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Association Between Geranylgeranyl Pyrophosphate Synthase Gene Polymorphisms and Bone Phenotypes and Response to Alendronate Treatment in Chinese Osteoporotic Women.PMID 28031082Read ↗

Farnesyl Diphosphate Synthase Gene Associated with Loss of Bone Mass Density and Alendronate Treatment Failure in Patients with Primary Osteoporosis.Semantic proximity Read ↗

The analysis of DKK1 polymorphisms in relation to skeletal phenotypes and bone response to alendronate treatment in Chinese postmenopausal women.Semantic proximity Read ↗

Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates.Semantic proximity Read ↗

Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.Semantic proximity Read ↗

LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.Semantic proximity Read ↗

Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin.Semantic proximity Read ↗

Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.Semantic proximity Read ↗

Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women.Semantic proximity Read ↗

Decrease in serum nucleotide pyrophosphatase activity in ankylosing spondylitis.Semantic proximity Read ↗

[Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.